Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.6995
+0.0045 (0.65%)
At close: Feb 27, 2026

BCLI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8131360145143
Market Cap Growth
-23.97%-3.18%-77.69%-58.70%1.59%47.63%
Enterprise Value
8141557123116
Last Close Price
0.702.274.0924.6060.0067.87
PB Ratio
-1.00-1.67-2.75-19.887.504.03
P/TBV Ratio
----7.514.03
Debt / Equity Ratio
-0.06-0.13-0.26-1.360.260.20
Net Debt / Equity Ratio
-0.05-0.110.01-0.37-0.88-0.98
Net Debt / EBITDA Ratio
-0.04-0.070.00-0.040.701.10
Net Debt / FCF Ratio
-0.06-0.090.00-0.060.640.98
Quick Ratio
0.010.030.170.353.513.76
Current Ratio
0.060.040.240.353.693.85
Return on Equity (ROE)
----297.38%-89.25%-273.75%
Return on Assets (ROA)
-400.07%-241.99%-211.70%-82.24%-38.09%-68.53%
Return on Capital Employed (ROCE)
142.60%163.60%596.90%7112.30%-106.90%-79.20%
Earnings Yield
-140.51%-89.78%-128.57%-40.51%-16.85%-22.27%
FCF Yield
--70.23%-153.13%-32.29%-18.33%-24.90%
Buyback Yield / Dilution
-78.11%-74.87%-17.99%-0.91%-21.22%-36.25%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.